{"first_author": "Angermeyer", "year": "1999", "pmid": "10457970", "citation_details": "NR", "study_design": "qualitative interview", "methodology_assessment": "problem-centred interview; baseline", "sample_size": "N=46 relatives", "respondent_type": "Caregivers/Family", "patient_diagnosis": "schizophrenia", "sociodemographics": "NR", "treatment_details": "clozapine treatment; NR", "experience_dimensions": "Positive perception/attitudes; Negative perception/attitudes; Side effects burden/discontinuation; Blood tests/monitoring burden; Perceived comparative effectiveness vs other antipsychotics; Caregiving burden/needs", "key_findings": "Relatives noted calming and sleep-improving effects; relatives were more aware of risks of discontinuing treatment; both groups complained about sedation and increased sleep need; diverging evaluations on hypersalivation, anticholinergic effects, and weight gain; relatives more concerned about long-term organ damage and haematotoxic effects; relatives showed slightly greater awareness of clozapine's advantages vs conventional neuroleptics", "notes_for_synthesis": "NR", "_timestamp": "2026-02-03T09:47:16.975063+00:00"}
{"first_author": "Boitz", "year": "1999", "pmid": "10457971", "citation_details": "NR", "study_design": "qualitative interview", "methodology_assessment": "problem-centred interview; timing: baseline (at discharge)", "sample_size": "N=80 patients", "respondent_type": "Patients", "patient_diagnosis": "schizophrenia", "sociodemographics": "NR", "treatment_details": "clozapine; duration of use/exposure: not specified; titration/monitoring: blood tests mentioned as obligatory; setting: in-patient or day hospital treatment; concomitant treatments: NR", "experience_dimensions": "Overall satisfaction; Positive perception/attitudes; Negative perception/attitudes; Sleep; Mood; Side effects burden/discontinuation; Blood tests/monitoring burden; Perceived comparative effectiveness vs other antipsychotics; Adherence; Refusal to start; Should have been started earlier; Patient participation/engagement", "key_findings": "Patients highlighted calming and relaxing effects and improved sleep as particularly positive; more than half expected worsening if they stopped medication; only every fifth feared relapse; fatigue and sedation were most often cited negative effects; absence of extrapyramidal side effects noted as advantage; only every tenth was aware of haemotopoietic system risks; many patients indifferent or had no opinion on blood tests", "notes_for_synthesis": "NR", "_timestamp": "2026-02-03T09:47:24.524604+00:00"}
